Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Kerkhoff

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Topics in Antiviral Medicine|August 14, 2024
CROI 2024: Tuberculosis, Mpox, and Other Infectious Complications in People With HIVAndrew D Kerkhoff, Jason Zucker, Diane V Havlir
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
In reply to 'C-reactive protein and tuberculosis screening: a new trick for an old dog?'Stephen D Lawn, Andrew D Kerkhoff, Robin Wood
Topics in Antiviral Medicine|May 13, 2026
CROI 2026: Tuberculosis and Other Infectious Complications in People With HIVAndrew D Kerkhoff, Jason Zucker, Diane V Havlir
AIDS (London, England)|February 25, 2011
Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis?Andrew D Kerkhoff, Robin Wood, Stephen D Lawn
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 18, 2012
Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impactStephen D Lawn, Andrew D Kerkhoff, Robin Wood
AIDS (London, England)|October 25, 2011
Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individualsStephen D Lawn, Andrew D Kerkhoff, Robin Wood
AIDS (London, England)|May 5, 2012
Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosisStephen D Lawn, Andrew D Kerkhoff, Monica Vogt, et al.
BMC Infectious Diseases|July 10, 2013
The proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: a systematic reviewAndrew D Kerkhoff, Ankur Gupta, Taraz Samandari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 19, 2013
Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assaysAndrew D Kerkhoff, Robin Wood, Monica Vogt, et al.
Plos One|July 31, 2014
Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosisAndrew D Kerkhoff, Robin Wood, Monica Vogt, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Topics in Antiviral Medicine|August 14, 2024
CROI 2024: Tuberculosis, Mpox, and Other Infectious Complications in People With HIVAndrew D Kerkhoff, Jason Zucker, Diane V Havlir
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 9, 2013
In reply to 'C-reactive protein and tuberculosis screening: a new trick for an old dog?'Stephen D Lawn, Andrew D Kerkhoff, Robin Wood
Topics in Antiviral Medicine|May 13, 2026
CROI 2026: Tuberculosis and Other Infectious Complications in People With HIVAndrew D Kerkhoff, Jason Zucker, Diane V Havlir
AIDS (London, England)|February 25, 2011
Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis?Andrew D Kerkhoff, Robin Wood, Stephen D Lawn
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 18, 2012
Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impactStephen D Lawn, Andrew D Kerkhoff, Robin Wood
AIDS (London, England)|October 25, 2011
Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individualsStephen D Lawn, Andrew D Kerkhoff, Robin Wood
AIDS (London, England)|May 5, 2012
Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosisStephen D Lawn, Andrew D Kerkhoff, Monica Vogt, et al.
BMC Infectious Diseases|July 10, 2013
The proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: a systematic reviewAndrew D Kerkhoff, Ankur Gupta, Taraz Samandari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 19, 2013
Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assaysAndrew D Kerkhoff, Robin Wood, Monica Vogt, et al.
Plos One|July 31, 2014
Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosisAndrew D Kerkhoff, Robin Wood, Monica Vogt, et al.
Pageof 11